L2 Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
|
|||||
|
2025
Q1 | $1.24M | Buy |
|
|||||
|
2024
Q4 | $1.04M | Buy |
|
|||||
|
2024
Q3 | $783K | Buy |
|
|||||
|
2024
Q2 | $611K | Buy |
|
|||||
|
2024
Q1 | $341K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $969K | Sell |
|
|||||
|
2023
Q2 | $1.34M | Sell |
|
|||||
|
2023
Q1 | $4.23M | Buy |
|
|||||
|
2022
Q4 | $3.55M | Buy |
|
|||||
|
2022
Q3 | $3.46M | Buy |
|
|||||
|
2022
Q2 | $3.09M | Buy |
|
|||||
|
2022
Q1 | $889K | Buy |
|
|||||
|
2021
Q4 | $328K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $243K | Sell |
|
|||||
|
2021
Q1 | $252K | Sell |
|
|||||
|
2020
Q4 | $582K | Sell |
|
|||||
|
2020
Q3 | $709K | Buy |
|